Prognostic implication of pulmonary function at the beginning of postoperative radiotherapy in non-small cell lung cancer

被引:9
|
作者
Kim, Hwanik [1 ]
Lussier, Yves A. [2 ,3 ,4 ]
Noh, O. Kyu [1 ,2 ,3 ,4 ]
Li, Haiquan [2 ,3 ,4 ]
Oh, Young-Taek [1 ]
Heo, Jaesung [1 ]
机构
[1] Ajou Univ, Sch Med, Dept Radiat Oncol, Suwon 441749, South Korea
[2] Univ Arizona, Dept Med, Tucson, AZ USA
[3] Univ Arizona, Inst BIO5, Tucson, AZ USA
[4] Univ Arizona, Leon Levy Canc Ctr, Tucson, AZ USA
关键词
Non-small cell lung cancer; Postoperative radiotherapy; Pulmonary function; Prognostic factor; END RESULTS DATABASE; RADIATION-THERAPY; STAGE-II; SURVIVAL; DISEASE; EPIDEMIOLOGY; SURVEILLANCE; CHEMOTHERAPY; METAANALYSIS; MORTALITY;
D O I
10.1016/j.radonc.2014.11.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The purpose of this study was to investigate the prognostic effect of pulmonary function at the beginning of postoperative radiotherapy (PORT) in non-small cell lung cancer (NSCLC). Materials and methods: From January 2002 to December 2012, 115 patients with NSCLC who underwent PORT and took the forced expiratory volume in 1 second (FEV1) at the beginning of PORT were analysed. PORT began within 4-6 weeks following surgery, and the 3-dimensional conformal technique was used with conventional fractionation. The high and low FEV1 groups were divided by the median absolute value of FEV1 at the beginning of PORT, and we compared the clinical factors and survival between two groups. Results: The median absolute value of FEV1 at the beginning of PORT was >= 1.68 L (range, 0.83-3.89), and patients were divided into low and high FEV1 groups (<1.68 L versus 1.68 L). Patients in the low FEV1 group showed a lower preoperative FEV1 (mean, 1.94 L versus 2.73 L, p < 0.001) and received more pneumonectomy (36.8% versus 8.6%, p < 0.001) compared to the high FEV1 group. The overall median follow-up time was 31 months (range, 3-110), and 5-year locoregional recurrence-free survival (LRRFS), distant metastasis-free survival (DMFS) and overall survival (OS) were 52.4%, 48.9%, and 45.9%, respectively. Five-year OS of the low FEVI group was significantly lower than that of the high FEVI group (35.4% versus 56.9%, p = 0.002), and no significant differences were found in LRRFS and DMFS. In a multivariate analysis, the difference of OS between the low and high FEV1 groups remained significant (Hazard Ratio = 2.04, Cl, 1.18-3.55, p = 0.011). Conclusions: The FEV1 at the beginning of PORT was an independent significant prognostic factor in patients with NSCLC who received PORT. Considering this analysis was limited to only patients receiving PORT, further studies are warranted to compare the survival effect of postoperative pulmonary function between groups with/without PORT. (C) 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc- nd/3.0/).
引用
收藏
页码:374 / 378
页数:5
相关论文
共 50 条
  • [1] Postoperative radiotherapy for non-small cell lung cancer
    Stewart, L
    Arriagada, R
    Brichet, AH
    Lafitte, JJ
    Burdett, S
    Girling, DJ
    Parmar, MKB
    Stephens, RJ
    Dautzenberg, B
    Debevec, M
    Kovac, V
    Gregor, A
    Piantadosi, S
    Pignon, J
    Rocmans, P
    Souhami, R
    Torri, V
    Van Houtte, P
    Trodella, L
    Wang, M
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2005, (02):
  • [2] Postoperative radiotherapy for non-small cell lung cancer
    Burdett, Sarah
    Rydzewska, Larysa
    Tierney, Jayne
    Fisher, David
    Parmar, Mahesh K. B.
    Arriagada, Rodrigo
    Pignon, Jean Pierre
    Le Pechoux, Cecile
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (09):
  • [3] Postoperative radiotherapy for non-small cell lung cancer
    Burdett, Sarah
    Rydzewska, Larysa
    Tierney, Jayne
    Fisher, David
    Parmar, Mahesh K. B.
    Arriagada, Rodrigo
    Pignon, Jean Pierre
    Le Pechoux, Cecile
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (10):
  • [4] Postoperative radiotherapy in non-small cell lung cancer
    Roelandts, M.
    Moretti, L.
    Van Houtte, P.
    [J]. CANCER RADIOTHERAPIE, 2011, 15 (6-7): : 514 - 517
  • [5] Role of Prognostic Nutritional Index in Postoperative Radiotherapy for Non-Small Cell Lung Cancer
    Ryu, H. J.
    Song, C.
    Kim, J. S., Jr.
    Jeon, J. H.
    Kim, K.
    Cho, S.
    Jheon, S.
    Kim, S. H.
    Kim, Y. J.
    Lee, J. S.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E388 - E388
  • [6] Role of Prognostic Nutritional Index in Postoperative Radiotherapy for Non-Small Cell Lung Cancer
    Ryu, H.
    Song, C.
    Kim, J. S.
    Jeon, J. H.
    Cho, S.
    Kim, K.
    Jheon, S.
    Kim, S. H.
    Kim, Y. J.
    Lee, J. S.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1047 - S1048
  • [7] Role of prognostic nutritional index in postoperative radiotherapy for non-small cell lung cancer
    Ryu, Hyejo
    Song, Changhoon
    Kim, Jae-Sung
    Jeon, Jae Hyun
    Cho, Sukki
    Kim, Kwhanmien
    Jheon, Sanghoon
    Kim, Se Hyun
    Kim, Yu Jung
    Lee, Jong Seok
    [J]. THORACIC CANCER, 2023, 14 (28) : 2859 - 2868
  • [8] Postoperative radiotherapy in localized non-small cell lung cancer
    Rübe, C
    Nguyen, TP
    Fleckenstein, J
    Niewald, M
    [J]. LUNG CANCER, 2001, 33 : S29 - S33
  • [9] Prognostic implication of PTPRH hypomethylation in non-small cell lung cancer
    Sato, Taicashi
    Soejima, Kenzo
    Arai, Eri
    Hamamoto, Junko
    Yasuda, Hiroyuki
    Arai, Daisuke
    Ishioka, Kota
    Ohgino, Keiko
    Naoki, Katsuhiko
    Kohno, Takashi
    Tsuta, Koji
    Watanabe, Shun-Ichi
    Kanai, Yae
    Betsuyaku, Tomoko
    [J]. ONCOLOGY REPORTS, 2015, 34 (03) : 1137 - 1145
  • [10] Postoperative radiotherapy of non-small cell lung cancer gets ahead!
    Baust, Heinrich
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2007, 183 (05) : 287 - 289